Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer [Phase 2]
This clinical trial update notes the completion of a Phase 2 trial evaluating chemotherapy followed by surgery in women with stage II or sta…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer [Phase 2]
Phase 2 trial comparing preoperative regimens of trastuzumab with vinorelbine versus docetaxel/carboplatin/trastuzumab in HER2-positive brea…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Liver Safety Under Upfront Arimidex vs Tamoxifen [Phase 4]
Phase 4 trial comparing upfront anastrozole (Arimidex) to tamoxifen in breast cancer provides results focused on liver safety. The results w…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer [NA]
A completed breast cancer trial evaluating adjuvant doxorubicin/cyclophosphamide and paclitaxel with sorafenib, with results posted on 2013-…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer [Phase 2]
A Phase 2 trial evaluating a combination of docetaxel, vinorelbine, and filgrastim in women with stage IV breast cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluated the combination of trastuzumab and gefitinib in metastatic breast cancer, and the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: FR901228 in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating FR901228 in metastatic breast cancer (Stage IV), including male and recurrent breast cancer cases, has completed en…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer [Phase 3]
A Phase 3 trial comparing a standard doxorubicin/cyclophosphamide/paclitaxel regimen with or without filgrastim in women with inflammatory o…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer [Phase 3]
Phase 3 clinical trial update for S9927 evaluating radiation therapy after surgery and systemic therapy in stage II breast cancer. The study…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer [Phase 3]
The SWOG S9623 Phase 3 trial evaluating combination chemotherapy plus peripheral stem cell transplantation for women with breast cancer has …
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating tamoxifen with or without combination chemotherapy in postmenopausal women after breast cancer surgery has…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating imatinib mesylate in patients with metastatic breast cancer has completed and was updated in ClinicalTrials.gov.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: PS-341 in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial of PS-341 (bortezomib) in women with metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients [Phase 3]
Phase 3 trial evaluating emend (aprepitant) to prevent delayed emesis in breast cancer patients receiving cyclophosphamide plus anthracyclin…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations [Phase 1]
Phase 1 trial results evaluate BAY86-9596 as a PET tracer for diagnostic imaging across cancer and inflammatory conditions. The study report…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer [Phase 2]
Phase 2 trial update on triptorelin for preserving ovarian function in premenopausal women undergoing chemotherapy for early-stage breast ca…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases [Phase 2]
Phase 2 trial of lapatinib ditosylate in combination with capecitabine for patients with Stage IV breast cancer and brain metastases; the st…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects [Phase 2]
The update announces termination of a Phase 2 trial evaluating lapatinib plus vinorelbine in ErbB2-overexpressing metastatic breast cancer, …
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery [Phase 2]
A Phase 2 trial evaluating trastuzumab with or without everolimus in women with surgically removable breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer [Phase 2]
Phase 2 trial of bevacizumab plus vinorelbine for stage IV breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema [NA]
This clinical trial evaluated traditional acupuncture for managing lymphedema caused by cancer treatment; the study is completed and results…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer [Phase 2]
A Phase 2 trial evaluating docetaxel in older patients with metastatic breast cancer, lung cancer, or prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer [Phase 3]
A Phase 3 trial evaluating combination chemotherapy with surgery and radiation, with or without Dexrazoxane and Trastuzumab, for stage III/I…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating triapine (3-AP) with gemcitabine for refractory metastatic breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors [NA]
Completed clinical trial from the University of Vermont evaluating weight loss interventions for overweight, postmenopausal breast cancer su…